Crotamiton Medicine Steroids Arimidex Fulvestrant Antineoplastic Drug CAS 129453-61-8

Post Date:
Nov 28,2016
Expiry Date:
May 27,2017
Detailed Description:
Cas No. :129453-61-8 Quantity: 1FCL
Price:1 USD Metric Tons
Payment Method: money gram & western union
Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor. It is administered as a once-monthly injection.
Fulvestrant is approved to treat breast cancer in postmenopausal women. It is used in patients with estrogen receptor positive breast cancer that has metastasized (spread to other parts of the body) after treatment with other antiestrogens.
Fulvestrant is also being studied in the treatment of other types of cancer.
CAS Registry Number:
129453-61-8
Synonyms:
;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;(17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;Faslodex;
Molecular Formula:
C₃₂H₄₇F₅O₃S
Molecular Weight:
606.7708
Molecular Structure:

Offter to Sell